Elicio Therapeutics Inc (ELTX)
8.84
-1.02
(-10.34%)
USD |
NASDAQ |
May 21, 16:00
8.84
0.00 (0.00%)
After-Hours: 20:00
Elicio Therapeutics Free Cash Flow: -36.68M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -36.68M |
| December 31, 2023 | -32.76M |
| Date | Value |
|---|---|
| September 30, 2023 | -29.01M |
| June 30, 2023 | -26.36M |
Free Cash Flow Range, Past 5 Years
-36.68M
Minimum
Mar 2024
-26.36M
Maximum
Jun 2023
-31.20M
Average
-30.89M
Median
Free Cash Flow Benchmarks
| Immuneering Corp | -50.39M |
| Outlook Therapeutics Inc | -58.26M |
| Amylyx Pharmaceuticals Inc | 15.44M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.12M |
| Cash from Investing (Quarterly) | 0.003M |
| Cash from Financing (Quarterly) | 11.02M |
| Free Cash Flow Per Share (Quarterly) | -1.180 |
| Free Cash Flow Yield | -52.93% |